Pomdoctor Revenue

In the year 2024, Pomdoctor had annual revenue of 342.56M CNY with 12.37% growth. Pomdoctor had revenue of 192.39M in the half year ending December 31, 2024, with 41.85% growth.

Revenue (ttm)

342.56M CNY

Revenue Growth

+12.37%

P/S Ratio

4.36

Revenue / Employee

2,195,884 CNY

Employees

156

Market Cap

640.77M undefined

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	342.56M	37.70M	12.37%
Dec 31, 2023	304.85M	59.64M	24.32%
Dec 31, 2022	245.22M	29.83M	13.85%
Dec 31, 2021	215.38M	74.18M	52.53%
Dec 31, 2020	141.21M	-44.33M	-23.89%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
UnitedHealth Group	435.16B
Johnson & Johnson	92.15B
Merck & Co.	63.62B
AbbVie	58.33B
AstraZeneca	56.50B
Novartis AG	56.37B
Eli Lilly and Company	53.26B
Novo Nordisk	49.11B

Revenue Rankings

POM News

14 days ago - Citi Appointed as Depositary Bank for POMDOCTOR LIMITED's ADR Program - Business Wire
21 days ago - U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown - Seeking Alpha
21 days ago - POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option - PRNewsWire
21 days ago - PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules - Benzinga
22 days ago - POMDOCTOR LIMITED Announces Closing of Initial Public Offering - PRNewsWire
23 days ago - POMDOCTOR LIMITED Announces Pricing of Initial Public Offering - PRNewsWire
3 months ago - PomDoctor Files For Nasdaq IPO That May Be Overvalued - Benzinga
8 months ago - PomDoctor Begins $15 Million U.S. IPO Rollout - Seeking Alpha

More News